logo

Sector: Pharmaceuticals & Biotechnology

|

Large Cap

Sun Pharmaceutical Share Price

SUNPHARMA

1,945

-6.00(-0.31%)
7th Aug 2026 | 3:14 PM
NSE : SUNPHARMA
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Sun Pharmaceutical Performance

Price Movement

₹1945.00

₹1925.10

₹1957.00

Today's LowToday's High

1 Year Performance

₹1945.00

₹1548.00

₹2046.90

52 Week Low52 Week High

Markets Today

High₹1,957.00
Low₹1,925.10
Open at₹1,955.00
Prev Close₹1,951.00
Volumes24.25 L
Avg Price₹1,937.87
Lower Circuit₹1,882.60
Upper Circuit₹1,999.00

Historical Performance

3M High₹2,046.90
3M Low₹1,756.80
1 Yr High₹2,046.90
1 Yr Low₹1,548.00
3 Yr High₹2,046.90
3 Yr Low₹1,068.35
5 Yr High₹2,046.90
5 Yr Low₹733.70

Summary

As of 10-08-2026 07:48, Sun Pharmaceutical Industries Ltd. share price today is ₹0, with a change of ₹-1951.00 (-100.00%) from the previous close of ₹1951. The stock opened at ₹1955 and traded between ₹1925.1 and ₹1957, with a total traded volume of 2425268 shares. The company has a market capitalization of ₹468110.3 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹2046.9 and ₹1548, respectively.

Sun Pharmaceutical Industries Ltd. valuation metrics include a P/E ratio of 38.7, EPS of ₹47.8, and book value of ₹5.60. Profitability indicators show ROE of 13.73% along with a dividend yield of 0.8%. Sun Pharmaceutical Industries Ltd. has reported revenue of ₹59910.52 Cr and net profit of ₹12095.58 Cr.

Sun Pharmaceutical Industries Ltd. technical indicators include Day RSI at 53.64, Day MFI at 58.06, Day ADX at 30.84. Additional indicators include Commodity Channel Index (CCI) at -28.6 and Williams %R at -78.8. Momentum indicators show Day MACD at 20.6, Day MACD Signal Line at 26.82, DayATR at 34.84. Rate of Change indicators for Sun Pharmaceutical Industries Ltd. include ROC125 at 19.85 and ROC21 at 3.33.

Exponential moving averages include EMA5 at ₹1958.3, EMA10 at ₹1961.2, EMA12 at ₹1959.9, EMA20 at ₹1949.2, EMA26 at ₹1939.3, EMA50 at ₹1902.6, EMA100 at ₹1851.1, EMA200 at ₹1798. Simple moving averages include SMA5 at ₹1961.8, SMA10 at ₹1969.2, SMA20 at ₹1957, SMA30 at ₹1934.2, SMA50 at ₹1885.2, SMA100 at ₹1830, SMA150 at ₹1789.5, SMA200 at ₹1779.

Support levels for Sun Pharmaceutical are placed at First Support ₹1932.03, Second Support ₹1913.07, Third Support ₹1896.13. Resistance levels are seen at First Resistance ₹1967.93, Second Resistance ₹1984.87, Third Resistance ₹2003.83. Sun Pharmaceutical Industries Ltd. shareholding pattern shows promoter holding at 54.48%, FII holding at 14.54%, DII holding at 0%, public holding at 8.81%.

Sun Pharmaceutical Fundamentals

Market Cap
Market Leader
4,68,110.30 Cr.
PE Ratio (TTM)
Above industry Median
38.70
Dividend Yield
Above industry Median
0.80
Net Profit TTM
16.6% incr over last year
12,095.58
Net Profit Growth
16.6% incr over last year
12,095.58
PEG Ratio
High in industry
2.30
ROE
9% decr over last year
13.73
Operating Revenue TTM
59,910.52
Operating Revenue Growth
11.4% incr over last year
Book Value
Above industry Median
5.60
MFI
MFI is mid-range
58.06
RSI
RSI is mid-range
53.64
EPS (TTM)
47.80
Debt to Equity
0.05
Face Value
1
Operating Profit Margin Qtr.
29.34
Operating Profit Qtr.
4,417.67
Net Profit Qtr.
2,894.79
Operating Revenue Qtr.
15,299.88
PB Ratio
5.60

Sun Pharmaceutical Financials

*All values are in Rs. Cr
Loading chart...
Indicator
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Total Revenue5,741.134,923.885,687.774,548.115,601.96
Operating Expense3,776.923,594.913,929.173,364.523,710.81
Operating Profit1,964.211,328.971,758.601,183.591,891.15
Depreciation307.92325.97338.53336.30299.03
Interest278.48216.92244.17248.33223.29
Tax379.24215.02482.06107.53431.35
Net Profit1,115.14608.70705.44564.22753.53

SUNPHARMA Stock Recommendation by HDFC

View Call ↗

Research Type

Equity , Long Term

Buy Range

1,781 - ₹1,814

Target Price

2,052

Stop Loss

-

Target Date

15 Mar 27

Potential Returns

15.22 %

View Call ↗

Sun Pharmaceutical Technicals

Sun Pharmaceutical Industries Ltd. EMA & SMA

1945.00

5.00 (0.26%)

Bullish Moving Average

10

Bearish Moving Average

6

Day EMA5 ₹1958.3
Day EMA10 ₹1961.2
Day EMA12 ₹1959.9
Day EMA20 ₹1949.2
Day EMA26 ₹1939.3
Day EMA50 ₹1902.6
Day EMA100 ₹1851.1
Day EMA200 ₹1798

Sun Pharmaceutical Support and Resistance

Resistance

First Resistance₹1967.93
Second Resistance₹1984.87
Third Resistance₹2003.83

Support

First Support₹1932.03
Second Support₹1913.07
Third Support₹1896.13

Technical Indicators

Day RSI53.64
Day MFI58.06
Day ADX30.84
Day Commodity Channel Index-28.60
William-78.80
Day MACD20.60
Day MACD Signal Line26.82
Day ATR34.84
Day ROC12519.85
Day ROC213.33

Sun Pharmaceutical Shareholding Pattern

Held ByMar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoter54.554.554.554.554.554.5
FII1817.316.616.115.914.5
DII18.619.520.220.921.122.2
Public8.98.58.78.68.58.8

Sun Pharmaceutical Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day12.27 L20.12 L61.02%
Week19.76 L31.71 L62.32%
1 Month18.95 L28.74 L65.94%
6 Month20.69 L32.64 L63.37%

Sun Pharmaceutical SWOT Analysis

Strengths15
Weakness7
Opportunity8
Threats0

Benjamin Graham Value Screen

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with high TTM EPS Growth

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Near 52 Week High

Negative to Positive growth in Sales and Profit with Strong Price momentum

Top Gainers

Stocks near 52 Week High with Significant Volumes

Sun Pharmaceutical Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
07 Jul, 20265FINAL07 Jul, 2026Equity Share
05 Feb, 202611INTERIM05 Feb, 2026Equity Share
07 Jul, 20255.5FINAL07 Jul, 2025Equity Share
06 Feb, 202510.5INTERIM06 Feb, 2025Equity Share
12 Jul, 20245FINAL12 Jul, 2024Equity Share
09 Feb, 20248.5INTERIM09 Feb, 2024Equity Share
28 Jul, 20234FINAL28 Jul, 2023Equity Share
08 Feb, 20237.5INTERIM08 Feb, 2023Equity Share
19 Aug, 20223FINAL22 Aug, 2022Equity Share
09 Feb, 20227INTERIM10 Feb, 2022Equity Share

Sun Pharmaceutical Stock Comparison

Financials
Price (₹)₹1,558.70₹840.50₹1,356₹1,982₹2,456₹209.80
% Change1.65%1.80%-4.07%2.34%1.48%0.75%
Revenue TTM (₹ Cr)₹1,753.96₹2,002.34₹2,192.49₹9,683.45₹14,737.88₹9,205.28
Net Profit TTM (₹ Cr)₹246.74₹575.94₹348.91₹1,011.39₹2,042.67₹-313.62
PE TTM102.9080.7086.0036.3048.90-88.40
1 Year Return216.1613.9678.236.17-5.3211.76
ROCE24.3227.5618.3825.6514.322.29

FAQ's on SUNPHARMA

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy